Nymox Pharmaceutical Corporation (NYMX) : Traders are bullish on Nymox Pharmaceutical Corporation (NYMX) as it has outperformed the S&P 500 by a wide margin of 3.83% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 52.63%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 51.63% in the last 1 week, and is up 3.61% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
For this week, the average consensus of the company shares are rated as a Strong Buy. The stock has recorded a twenty day Moving Average of 27.7% and the fifty day Moving Average is 18.4%. Nymox Pharmaceutical Corporation is up 58.05% in the last three month period. Year-to-Date the stock performance stands at 13.72%.
Nymox Pharmaceutical Corporation (NASDAQ:NYMX): On Fridays trading session , Opening price of the stock was $4.8 with an intraday high of $4.8. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $3.5. However, the stock managed to close at $3.73, a loss of 23.72% for the day. On the previous day, the stock had closed at $4.89. The total traded volume of the day was 5,536,263 shares.